Lundbeck Inc. (formerly Ovation Pharmaceuticals) Release: Sabril(R) Now Available in U.S. for Patients with Two Difficult-to-Treat Epilepsies

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck Inc. (“Lundbeck”), a wholly owned subsidiary of H. Lundbeck A/S in Denmark (Copenhagen: LUN), announced today that Sabril® (vigabatrin) Tablets and Powder for Oral Solution are now available for prescribing in the United States.